- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06261437
Effect of Ration Formulations on Warfighter Energy Balance and Physical Performance During a Field Training Exercise
The goal of this randomized clinical trial is to determine the effects of consuming the Close Combat Assault Ration (CCAR) compared to the First Strike Ration (FSR) during a 7-day strenuous military training on energy intake and energy balance in healthy, Active Duty Warfighters.
The main questions it aims to answer are:
- Will consuming the CCAR result in lower energy intake or energy balance compared to consumption of the FSR?
- Will consuming the CCAR result in lower lower body strength or anaerobic power compared to consuming the FSR?
- Will those consuming the CCAR report lower ration acceptability or greater gastrointestinal side effects compared to those consuming the FSR?
Participants will be asked to consume either the CCAR or FSR as the sole nutrition source during a 7-day field training exercise (FTX). The vertical jump test, running-based anaerobic sprint test, and lower-body strength pull will be conducted pre and post the 7-day FTX to assess physical performance. Energy expenditure and intake will be measured by the doubly-labelled water method and dietary logs, respectively. Surveys will be completed to assess ration acceptability and gastrointestinal symptoms.
Researchers will compare the CCAR and FSR groups to see if their consumption impacted energy intake, energy balance, physical performance, ration acceptance, or gastrointestinal side effects.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Army modernization priorities have identified the need to build the "capability to sustain multiple Brigade Combat Teams for up to seven days without periodic resupply to support semi-independent operations". To address this challenge and meet modernization requirements, ration developers from the Combat Feeding Division (CFD), Soldier Sustainment Directorate, Combat Capabilities Development Command - Soldier Center (DEVCOM-SC) developed the next generation ration, the Close Combat Assault Ration (CCAR). The CCAR is produced using novel food processing techniques that reduce weight and volume by removing air and water and increase the energy density by increasing the relative fat content. The result is a lightweight, low volume, energy-dense, shelf-stable, daily combat assault ration that provides Warfighters with meals that can be consumed while on the move, requiring no heating and little to no field preparation.
The ration will provide approximately 2800 kcals/day (47% carbohydrate, 12% protein, 41% fat) and includes a greater distribution of energy from fat to enable a smaller logistic footprint than the First Strike Ration (FSR, 2800 kcals/d; 58% carbohydrate, 12% protein, 30% fat).
This proposed project will evaluate the CCAR relative to the current recommended materiel solution (i.e., the FSR) in a field setting that approximates the operational conditions under which the ration will be consumed. Specifically, the proposed effort will compare energy intake, energy balance, physical performance, appetite, ration acceptability, and gastrointestinal responses in military personnel randomized to consume the CCAR or FSR in a multi-day training environment.
Participants will be randomized to consume the CCAR or FSR during a 7-day field training exercise. Physical performance will be assessed PRE and POST by the Running-Based Anaerobic Sprint Test, lower-body strength pull, and vertical jump. A subset of participants will consume doubly-labeled water and provide urine samples throughout the study period to measure energy expenditure. Appetite, ration acceptability, and gastrointestinal symptoms will be assessed by daily surveys. Energy intake will be measured by review of uneaten ration products and daily logs.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michael A Dawson, PhD
- Phone Number: 508-206-2278
- Email: michael.a.dawson62.mil@health.mil
Study Locations
-
-
Massachusetts
-
Natick, Massachusetts, United States, 01760
- U.S. Army Research Institute of Environmental Medicine
-
Contact:
- USARIEM
- Phone Number: 508-206-2200
- Email: usarmy.natick.medcom-usariem.mbx.usariem-webmaster@health.mil
-
Principal Investigator:
- Michael A Dawson, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Active-duty male or female military personnel who are actively participating in the 7-day strenuous military training exercise.
- Willing to consume only foods/beverages provided by study staff during the training exercise, except for coffee and water.
Exclusion Criteria:
- Any injury or health condition limiting full participation in the 7-day Field Training Exercise.
- Any food allergy, lactose intolerance, or vegetarian practices.
- Not willing to participate in all study procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Close Combat Assault Ration
The CCAR will be consumed as the sole nutrition source during a 7-day physically demanding military training exercise
|
The CCAR will be consumed as the sole source of nutrition during a 7-day military training exercise.
|
Active Comparator: First Strike Ration
The FSR will be consumed as the sole nutrition source during a 7-day physically demanding military training exercise
|
The FSR will be consumed as the sole source of nutrition during a 7-day military training exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Energy intake
Time Frame: From study day 1 through 7
|
Energy intake will be measured with daily food records and a review of food waste.
|
From study day 1 through 7
|
Energy expenditure
Time Frame: From baseline to study day 7
|
Energy expenditure will be measured using the doubly-labeled water method.
|
From baseline to study day 7
|
Energy balance
Time Frame: From baseline to study day 7.
|
Energy balance will measure the difference between energy intake and expenditure.
|
From baseline to study day 7.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical performance (vertical jump)
Time Frame: At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
The maximum height of the vertical jump will be measured in cm.
|
At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
Physical performance (peak power)
Time Frame: At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
Peak power will be calculated from the vertical jump measure using the following equation: Peak Power (Watts) = [60.7 x jump height (cm)] + [45.3 x body mass (kg)] - 2055 |
At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
Physical performance (Anaerobic capacity)
Time Frame: At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
Anaerobic capacity will be measured by the time to complete the Running-Based Anaerobic Sprint Test.
|
At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
Physical performance (lower-body strength)
Time Frame: At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
Lower-body isometric strength will be measured using a Takei Back and Leg Dynamometer.
The maximum strength (kg) during three trials will be used for analysis.
|
At baseline (PRE) and POST the 7-day FTX (i.e., study day 8)
|
Food acceptance scale
Time Frame: From study day 1 through 7
|
Food acceptance will be measured using a version of the Food Action Rating Scale.
The Food Action Rating Scale is a Likert scale that measures food acceptance on a scale of 1-9.
The scale ranges from dislike extremely (1) to like extremely (9).
|
From study day 1 through 7
|
Gastrointestinal Quality of Life Index
Time Frame: From baseline to study day 8
|
Gastrointestinal quality of life will be measured using a modified version of the Gastrointestinal Quality of Life Index (GIQLI).
Ratings of abdominal bloating, pain, nausea, and gastrointestinal discomfort will be assessed using a 100mm visual analog scale with values corresponding a range of symptoms (0; no symptoms to 100; extremely severe).
The sum of the scores will represent GIQLI.
|
From baseline to study day 8
|
Hunger and Satiety Visual Analog Scales
Time Frame: From baseline to study day 8
|
Ratings of subjective appetite sensations will be measured using 100 mm visual analog scales (VAS).
Subjective ratings of hunger, fullness, desire to eat, and capacity to eat will be annotated on a 100mm line ranging from none (e.g., 0; Not at all hungry) to extremely (e.g., 100; extremely full).
|
From baseline to study day 8
|
Collaborators and Investigators
Investigators
- Principal Investigator: Michael A Dawson, PhD, United States Army Research Institute of Environmental Medicine
Publications and helpful links
General Publications
- Margolis LM, Rood J, Champagne C, Young AJ, Castellani JW. Energy balance and body composition during US Army special forces training. Appl Physiol Nutr Metab. 2013 Apr;38(4):396-400. doi: 10.1139/apnm-2012-0323. Epub 2013 Apr 3.
- Hoyt RW, Jones TE, Baker-Fulco CJ, Schoeller DA, Schoene RB, Schwartz RS, Askew EW, Cymerman A. Doubly labeled water measurement of human energy expenditure during exercise at high altitude. Am J Physiol. 1994 Mar;266(3 Pt 2):R966-71. doi: 10.1152/ajpregu.1994.266.3.R966.
- Karl JP, Hatch-McChesney A, Allen JT, Fagnant HS, Radcliffe PN, Finlayson G, Gwin JA, Margolis LM, Hennigar SR, McClung JP, Pasiakos SM. Effects of energy balance on appetite and physiological mediators of appetite during strenuous physical activity: secondary analysis of a randomised crossover trial. Br J Nutr. 2021 Nov 28;126(10):1571-1584. doi: 10.1017/S0007114521000131. Epub 2021 Jan 14.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- M-11053
- MO230060 (Other Grant/Funding Number: Military Operational Medicine Research Program (MOMRP))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on CCAR
-
iCell Gene TherapeuticsThe General Hospital of Western Theater Command; Peking University Shenzhen... and other collaboratorsRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myeloid Leukemia | Hematologic Malignancy | Myeloproliferative NeoplasmChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...UnknownMultiple MyelomaChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Plasmacytoid; LymphomaChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...UnknownAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myeloid Leukemia | Hematologic Malignancy | Myeloproliferative NeoplasmChina
-
iCell Gene TherapeuticsiCAR Bio Therapeutics Ltd. ChinaRecruitingRelapsed/Refractory, Systemic Lupus Erythematosus (SLE)China
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...UnknownB Cell Lymphoma | B Cell LeukemiaChina